Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TEAD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MRAS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMTA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DKFZP586I1420 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CA5BP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMIM19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TSLP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ERC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928718 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPATA6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COLGALT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRMT5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYBBP1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMIM2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on